Lipocine Inc. (LPCN) earnings
Quarterly results of Lipocine Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Lipocine Inc. was expected to report around October 16, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Lipocine Inc. reported revenue of $190.1K (-69.5% on the same quarter a year earlier) and a net loss of $2.6M.
Diluted earnings per share were -$0.32.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $190.1K | -69.5% | -$2.6M | -$0.32 |
| Q1 FY2026 | $119.4K | +27.2% | -$3.7M | -$0.54 |
| Q4 FY2025 | $1.1M | - | -$2.4M | - |
| Q3 FY2025 | $114.6K | - | -$3.2M | -$0.59 |
| Q2 FY2025 | $622.8K | - | -$2.2M | -$0.41 |
| Q1 FY2025 | $93.9K | - | -$1.9M | -$0.35 |
| Q4 FY2024 | - | - | $1.8M | - |
| Q3 FY2024 | - | - | -$2.2M | -$0.44 |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Lipocine Inc.'s next earnings date?
Lipocine Inc. was expected to report around October 16, 2026; nothing is on file with the SEC yet.
What were Lipocine Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Lipocine Inc. reported revenue of $190.1K and a net loss of $2.6M. The figures come from its filing with the SEC.
Is Lipocine Inc.'s revenue growing?
Revenue in Q2 FY2026 was $190.1K, down 69.5% from $622.8K in the same quarter a year earlier.
Get an email when LPCN reports
Follow LPCN and we email you its next results the day they are filed, with the numbers explained.